Daniel Pearlstein
Daniel Pearlstein is an equity research analyst with M Partners covering the Life Sciences sector. His previous experience includes analyst roles at a North American healthcare venture capital firm, a medical device startup and a technology transfer incubator. Pearlstein holds a bachelor's degree in chemistry and a master's degree in management.
Recent Quotes
"CYNA finished Q2/15 with over $111M in cash; it is well capitalized."
—
Daniel Pearlstein, M Partners
(8/19/15)
more >
Due to permission requirements, not all quotes are shown.